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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 


















 This perspective aims to 
provide practical support 
for the planning of 
delivery, resuscitating, 
stabilizing, and providing 
postnatal care to an infant 
born to a mother with 
suspected or confirmed 
COVID-19 in low-
resource settings where 
resources for managing 


















 This review, identifies 
cases and deaths in 18 
most affected countries by 
COVID-19 cases and 














for the differing fatality 
rates. 
 Countries with significant 
percentage of older 
population are vulnerable 
to a high number of deaths 
due to COVID-19. 
Developed countries have 
higher per capita testing, 
whereas testing is less 
intensive in 
developing/underdeveloped 
countries. There is a 
consensus among health 
experts that COVID-19 has 
higher fatality rates for 
people above 60, however, 
with further age, this 
increases exponentially. 
Countries with higher life 
expectancy are also high-
income countries, and the 
best course of action would 
be to provide specialized 
support to self-isolate for 
people of ages 75 and 
above. 
  
























 The findings suggest a 
possible risk of fecal-oral, 
foodborne, and 
waterborne transmission 
of SARS-CoV-2 in 
developing countries that 
often use sewage-
polluted waters in 
irrigation and have poor 
water treatment systems. 
CoVs survive longer in 
the environment at lower 
temperatures and lower 
relative humidity. It has 
been suggested that large 
numbers of COVID-19 
cases are associated with 





temperate regions of the 
world and that seasonality 
of the virus spread is 
suspected. 






19.06.2020 Increase in 













 Lockdown due to the 
Coronavirus disease 2019 
(COVID 19) pandemic may 
cause weight gain and 
enhance the risk of type 2 
diabetes mellitus (T2DM). 
We aimed to determine this 
risk in apparently non-
diabetic individuals. 
 There was a trend towards 
weight gain seen in 40% of 
the cohort, with 16% of the 
population experiencing a 
2.1-5 kg weight increment. 
When all the risk 
parameters were analyzed 
together using the ADA risk 
engine, there was an 
increase in the ADA 
diabetes risk score in 7% of 
the population, with 6.66% 
in the high-risk group. 
There was a further 
increase in weight among 
3% of the population who 
were already obese at 
baseline. 
Diabetes 


















providers must ensure that 
a safe clinic and hospital 
environment is created for 
children with both COVID-
19 and non-COVID-19 
related illnesses so that 
essential preventive care 
and health maintenance 
can be provided to children 
during this time.  
 It is essential to continue to 
spread public health 
awareness messages about 






infection and about the 
importance of routine 
immunisations and seeking 
appropriate advice from 
healthcare providers when 
necessary.  
 If parents are reassured 
that healthcare providers 
will follow standard 
operating procedures and 
will wear and provide 
appropriate PPEs, they may 
be more likely to seek 
appropriate and timely care 
for their children. 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | 
Article type 
Author(s) 
29.06.2020 Covid-19: Oxford Team Begins Vaccine 
Trials in Brazil and South Africa to Determine 
Efficacy 
BMJ | News Elisabeth 
Mahase 
30.06.2020 The line is forming for a COVID-19 vaccine. 
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  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 






      
Global 5050 









  US  COVID-19 
Primer 




     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 





              
C19 Resource Hubs 









  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
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g in low 
resource 
settings 




















Cochrane  Center for Global 
Development 




















Institute of Public 
Health 
    





Oxford Centre for 
Evidence-based 
Medicine 
    




 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 




  SSRN 
(Preprints)  
      













      
WorldPop           
Flowminder           





    
  
GISAID           
Online learning & events 








treatment of severe 
COVID-19  






mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
2020 UCL-Lancet 
Lecture: Global Health 










Global Director for 
Health, Nutrition and 




June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 







Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 











Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 




Modelling and Policy 
Online 
learning 













Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
10 




5 hours Johns Hopkins 




Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 











COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 





COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 




19: Real-time training 


















































Edinburgh & Royal 
College of Physicians 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
  
12 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
